Fed Circuit rejects Cellect rehearing on double patenting
En banc petition concerning obviousness-type double-patenting rejected by the Court of Appeals | Decision on patent term adjustment has been closely followed by pharma companies, NYIPLA, and AIPLA.
Perry Shutterstock Fed Circuit Fus Court Of Appeals For The Federal Circuit Patent Trial And Appeal Board Us Patent And Trademark Office Bviousness Type
Source: worldipreview.com